Lipomatosis
Lipomatosis, also called multiple or symmetric lipomatosis, is a group of rare disorders in which mature fat cells (adipocytes) proliferate abnormally, infiltrate surrounding tissue and build up diffusely in several areas of the body. A solitary lipoma is a single benign growth with a well-defined fibrous capsule. Lipomatosis is different: it reflects a metabolic or inherited disorder of fat tissue in which fatty masses arise at many sites, usually without a capsule, infiltrate muscle, omentum or internal organs, and tend to progress, distorting body shape or seriously compressing nerves and blood vessels.
From a clinical and dermato-oncology standpoint, lipomatosis covers several forms with distinct genetic and causal features, including Madelung disease (multiple symmetric lipomatosis, MSL, or benign symmetric lipomatosis), Dercum disease (adiposis dolorosa), Proteus syndrome and familial multiple lipomatosis (FML). Although the fat cells are benign and mature, the risk of compressing the airway, esophagus and major vessels of the neck and chest (in Madelung disease), or of body deformity with chronic pain (in Dercum disease), makes these conditions very challenging to manage.
At Haute-Derma, we follow an evidence-based pathway for lipomatosis: detailed imaging (superfine ultrasound and MRI), classification by genetic and metabolic subtype, then treatment with enzyme micro-injection lipolysis, power- or ultrasound-assisted liposuction (PAL/UAL) and tissue-sparing surgical excision to restore body contour and relieve pressure on vital structures.
Clinical Features and Pathological Classification
Classic Clinical Forms of Lipomatosis
- Madelung disease (multiple symmetric lipomatosis, MSL; benign symmetric lipomatosis; Launois-Bensaude syndrome):
- Cause: strongly associated with chronic alcohol use (more than 90% of cases) and mitochondrial damage (mitochondrial DNA mutations, notably m.8344A>G).
- Features: extensive, symmetric, unencapsulated fat deposits around the neck (the "horse collar" or "Bacchus neck"), shoulders, upper chest and roots of the upper limbs.
- Enzi classification:
- Type I: fat concentrated symmetrically on the neck, shoulders, clavicular area and upper arms.
- Type II: fat extending down to the hips, thighs and buttocks, resembling lower-body obesity.
- Type III: a congenital form seen in children.
- Complications: tracheal compression causing breathlessness, esophageal compression causing difficulty swallowing, jugular vein compression, and peripheral neuropathy related to alcohol or mitochondrial dysfunction.
- Dercum disease (adiposis dolorosa, neurolipomatosis):
- Features: multiple small fatty lumps, soft or slightly firm, causing severe chronic pain either spontaneously or with the lightest touch. The pain does not respond to standard NSAIDs.
- Who gets it: most often postmenopausal women with obesity and coexisting mood disorders or depression.
- Pain mechanism: infiltrating fat pressing directly on fine sensory nerve fibers in the skin, or chronic inflammation within the fat tissue.
- Familial Multiple Lipomatosis (FML):
- Cause: autosomal dominant inheritance.
- Features: dozens to hundreds of small encapsulated lipomas on the forearms, thighs and trunk, usually sparing the neck and shoulders. Onset is in adulthood; the lumps are painless and unrelated to alcohol use.
- Proteus Syndrome and Related PIK3CA Fatty Overgrowth Disorders: disproportionate, malformed overgrowth of fat, fibrous connective tissue, bone and blood vessels caused by somatic mosaic mutations in AKT1 or PIK3CA.
Histopathology
- Mature adipocytes: under the microscope, lipomatosis shows fully mature univacuolar fat cells whose nuclei are pushed to the edge by a single large lipid droplet.
- Infiltrating fibrovascular stroma:
- Madelung disease: no fibrous capsule; strands of fat weave directly between muscle bundles and nerve sheaths.
- Dercum disease: increased density of small blood vessels and an inflammatory infiltrate of mast cells and lymphocytes around fine sensory nerves.
- Brown fat phenotype: the fat in Madelung disease shares biochemical and anatomical features with brown adipose tissue, attributed to dysregulated beta-adrenergic receptor signaling.
Differential Diagnosis and Immunohistochemistry (IHC)
| Condition | Distinguishing Histology / Imaging / Immunohistochemistry (IHC) |
|---|---|
| Lipomatosis (Madelung / Dercum / FML) | Uniform benign mature fat cells; no atypical cells or mitoses; MDM2 (−); CDK4 (−); S100 (+). |
| Well-differentiated liposarcoma (WDLPS) | Malignant fatty tumor; lipoblasts (multivacuolated immature fat cells) and atypical hyperchromatic nuclei; MDM2/CDK4 amplification (+), which must be confirmed by FISH/IHC. |
| Solitary lipoma | Single fatty tumor with a well-defined fibrous capsule that shells out easily; not symmetric and without diffuse chronic pain. |
| Angiolipoma | Painful benign lipoma; microscopy shows small fibrin microthrombi within abundant proliferating capillaries; CD31 (+); ERG (+). |
| Generalized obesity | Fat distributed evenly over the body without discrete masses or well-demarcated fatty plaques; no compression of deep neck or chest structures. |
Our Approach to Treating Lipomatosis
Haute-Derma manages lipomatosis according to three principles: Relieve Compression, Restore Contour, Prevent Recurrence.
- Comprehensive cross-sectional imaging (CT/MRI): for Madelung disease, MRI or CT of the neck, chest and limbs is mandatory to map how the fat infiltrates around the trachea, carotid arteries and nerve plexuses before any procedure.
- Addressing nutritional and metabolic drivers: complete abstinence from alcohol (in Madelung disease) and control of blood lipids and glucose are prerequisites for halting growth of the fatty masses.
- Multimodal treatment: surgical debulking for deep masses, laser- or ultrasound-assisted liposuction (UAL/LAL) for diffuse superficial fat, and enzyme micro-injection lipolysis for small residual deposits.
How We Diagnose Lipomatosis at Haute-Derma
- History and genetic or metabolic risk factors: we assess long-term alcohol intake, family history of multiple lipomas (FML), the severity of chronic pain (Dercum disease) and any compressive symptoms such as breathlessness when lying flat, difficulty swallowing or hoarseness.
- High-resolution (superfine) ultrasound: shows the thickness of the fat, whether a capsule is present, how vascular it is and how it relates to the deep muscle fascia.
- MRI / CT: mandatory for Madelung disease of the neck and chest. It defines exactly how far the fat extends into the anterior mediastinum, the retroesophageal space and the carotid sheath.
- Core needle biopsy and immunohistochemistry: performed if a mass grows unusually fast or shows mixed signal on MRI, so that MDM2/CDK4 amplification testing can rule out liposarcoma.
Specialized Treatments at Haute-Derma
- Laser- or ultrasound-assisted liposuction (LAL/UAL): our first choice at Haute-Derma for diffuse Madelung disease and for Dercum disease. A 1470 nm laser or ultrasound energy liquefies the firm, fibrous fat without tearing vessels or nerves, and the fat is then gently suctioned out. This reshapes the neck, shoulders and thighs without long surgical scars.
- Open surgical debulking or excision of deeply infiltrating fat: indicated for Madelung masses that extend deep between muscles or surround the trachea or carotid arteries and cause breathing or swallowing problems. The surgeon carefully dissects the fat lobe by lobe to decompress these vital structures safely.
- Enzyme micro-injection lipolysis (mesotherapy): micro-injections of deoxycholic acid (DCA) combined with phosphatidylcholine (PPC) and hyaluronidase break down fat cell membranes and loosen fibrous tissue. This works particularly well for the small scattered lipomas of familial multiple lipomatosis (FML) and for residual fat after surgery.
- Medical Treatment and Pain Management in Dercum Disease: neuromodulating drugs (pregabalin, gabapentin), local lidocaine injections and rehabilitative exercise therapy are combined to ease chronic pain.
